IBB vs PBE

iShares Biotechnology ETF against Invesco Biotechnology & Genome ETF: cost, size, returns, what they hold and how much of it is the same.

Overlap by weight
42%
24 shared positions
Fee gap
14 bp
IBB is cheaper
1-year return gap
1.4 pts
IBB is ahead
Larger fund
IBB
$10.8B

Side by side

IBBPBE
FundiShares Biotechnology ETFInvesco Biotechnology & Genome ETF
IssueriSharesInvesco
CategoryBiotech & Health InnovationBiotech & Health Innovation
Expense ratio0.44%0.58%
Assets$10.8B$422M
Average daily dollar volume$343M$1.7M
ListedFeb 5, 2001Jun 23, 2005
FrenzyCap score8349
1-month return+1.9%+4.2%
3-month return+8.9%+7.0%
Year to date+22.4%+17.9%
1-year return+35.9%+34.5%
30-day volatility23.0%22.6%
Worst drawdown, 1 year−9.7%−11.8%
Trailing 12-month yield0.17%1.38%
Holdings24833
Top 10 weight49.9%48.4%
Look-through P/E—106.3
Holdings vs fair value−0.0%+8.1%
Holdings above 200-day average77%78%
Net flow, latest 3 reported months−$43M thru Jun 2026+$5.9M thru Jul 2026
30-day implied volatility24.1%25.9%
Holdings as ofas of Oct 8, 2026issuer dataas of Oct 8, 2026issuer data

Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.

Largest shared holdings

54% of IBB · 82% of PBE
HoldingIBBPBE
GILD8.37%5.17%
AMGN7.89%4.82%
VRTX7.70%4.76%
REGN5.40%4.64%
NTRA3.88%6.07%
MRNA5.30%3.54%
ILMN2.94%6.15%
BIIB2.36%5.17%
INCY1.67%2.48%
UTHR1.63%2.93%
NBIX1.05%2.63%
EXEL1.04%2.97%
HALO0.91%2.87%
BMRN0.77%2.37%
RGEN0.64%2.57%
PTGX0.63%2.65%
PTCT0.37%2.43%
VCYT0.25%2.82%
ACAD0.24%1.83%
VCEL0.15%2.64%
SRPT0.14%2.75%
BCRX0.13%2.41%
NVAX0.13%3.33%
ANAB0.09%2.26%

Sector mix of the stock holdings

SectorIBBPBEGap
Health Care95.1%91.3%+3.9%
Technology4.7%6.2%−1.4%
Materials0.0%0.0%+0.0%

More: full overlap table · IBB holdings · PBE holdings

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.